Skip to main content

Biocom’s “State of the Union: IPO Market in San Diego

When:

May 23, 2019 4:00 pmMay 23, 2019 5:30 pm (PDT)

Where:

The Alexandria at Torrey Pines
10996 Torreyana Road
San Diego, CA 92121

Registration Closed

The past two years have been strong for San Diego Biotech initial public offerings (IPO). The IPO window has improved the funding environment, enabling companies to build out their teams and turn their discoveries into commercial realities. While companies are constantly tweaking their R&D and innovation strategies, a major challenge for CEOs today is access to capital. The IPO process has given companies another avenue for raising capital. San Diego-based Synthorx, Equillium and Turning Point Therapeutics have all benefited from accessing public markets.

Biocom is pleased to announce our next exclusive panel discussion – Biocom’s “State of the Union: IPO Market in San Diego” – with three well-respected CEO’s scheduled to take place on Thursday, May 23rd. Speakers include:

Moderator:
Carin Canale-Theakston, CEO, Canale Communications Inc.

Panelists:
Daniel Bradbury, Chairman and CEO, Equillium
Athena Countouriotis, President and CEO, Turning Point Therapeutics
Laura Shawver, President, CEO, & Director, Synthorx

The panel provides an opportunity for a thoughtful panel discussion on how to turn today's challenges into tomorrow's opportunities. Join us, and hear local industry leaders give an overview of their companies, discuss IPO trends, successes and challenges and their journey through the IPO process.

Price of Admission

Biocom Member

Today’s Price: 30

Important Dates

Amount

Registration before

Registration before

Registration before

Registration cost

30

Refund before 2019-04-18

0

Refund before

Refund Before

Non-Member (Industry Only)

Today’s Price: 50

Important Dates

Amount

Registration before

Registration before

Registration before

Registration cost

50

Refund before 2019-04-18

0

Refund before

Refund Before

Registration Closed